On 2025-05-12, Urogen Pharma (URGN) announced earnings per share of $-0.92 for the fiscal quarter ending 2025-03-31, missing the average analyst estimate of $-0.83.
The next expected annoucement date for quarterly earnings is 2025-08-12, with an average estimated earnings per share of $-0.80 for the fiscal quarter ending 2025-06-30.
Note: Earnings figures are calculated as diluted earnings per share before non-recurring items and including employee stock options expenses.
| Announcement Date | Fiscal Quarter End | Estimated EPS | Actual EPS |
|---|---|---|---|
| 2025-05-12 | 2025-03-31 | $-0.83 | $-0.92 |
| 2025-03-10 | 2024-12-31 | $-0.74 | $-0.80 |
| 2024-11-06 | 2024-09-30 | $-0.84 | $-0.55 |
| 2024-08-13 | 2024-06-30 | $-0.82 | $-0.91 |
| 2024-05-13 | 2024-03-31 | $-0.93 | $-0.97 |
| 2024-03-14 | 2023-12-31 | $-0.67 | $-0.72 |
| 2023-11-14 | 2023-09-30 | $-0.89 | $-0.68 |
| 2023-08-10 | 2023-06-30 | $-1.13 | $-1.03 |
| 2023-05-11 | 2023-03-31 | $-1.39 | $-1.30 |
| 2023-03-16 | 2022-12-31 | $-1.12 | $-1.22 |
| 2022-11-10 | 2022-09-30 | $-1.22 | $-1.13 |
| 2022-08-11 | 2022-06-30 | $-1.33 | $-1.18 |
| 2022-05-10 | 2022-03-31 | $-1.36 | $-1.25 |
| 2022-03-21 | 2021-12-31 | $-1.18 | $-1.27 |
| 2021-11-15 | 2021-09-30 | $-1.26 | $-1.35 |
| 2021-08-04 | 2021-06-30 | $-1.10 | $-1.17 |
| 2021-05-13 | 2021-03-31 | $-1.26 | $-1.17 |
| 2021-03-18 | 2020-12-31 | $-1.31 | $-1.38 |
| 2020-11-09 | 2020-09-30 | $-1.47 | $-1.31 |
| 2020-08-10 | 2020-06-30 | $-1.55 | $-1.44 |
| 2020-05-07 | 2020-03-31 | $-1.61 | $-1.79 |
| 2020-03-02 | 2019-12-31 | $-1.69 | $-1.86 |
| 2019-11-12 | 2019-09-30 | $-1.26 | $-1.06 |
| 2019-08-09 | 2019-06-30 | $-1.20 | $-1.08 |
| 2019-05-09 | 2019-03-31 | $-1.12 | $-1.11 |
| 2019-02-28 | 2018-12-31 | $-1.29 | $-1.46 |
| 2018-11-12 | 2018-09-30 | $-1.08 | $-1.28 |
| 2018-08-14 | 2018-06-30 | $-0.91 | $-1.14 |
| 2018-05-15 | 2018-03-31 | $-0.73 | $-0.88 |
| 2018-03-15 | 2017-12-31 | $-0.65 | $-0.74 |
| 2017-11-14 | 2017-09-30 | $0.08 | $-0.02 |
| 2017-08-14 | 2017-06-30 | $-0.46 | $-0.70 |